L. Engelen

发表

Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.

O. Pedersen, A. Vaag, H. Parving, 2011, European journal of endocrinology.

Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database.

P. Dagnelie, C. Stehouwer, C. Schalkwijk, 2016, Food chemistry.

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.

C. Stehouwer, C. Schalkwijk, P. Rossing, 2018, Journal of diabetes and its complications.

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

H. Parving, L. Tarnow, C. Stehouwer, 2017, Cardiovascular Diabetology.

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

N. Chaturvedi, C. Stehouwer, C. Schalkwijk, 2015, Cardiovascular Diabetology.

Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies

E. Feskens, G. Nijpels, J. Dekker, 2009, Journal of hypertension.

Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.

H. Parving, C. Stehouwer, C. Schalkwijk, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors.

Stéphane Laurent, Pierre Boutouyrie, S. Laurent, 2013, European heart journal.

Current therapeutic interventions in the glycation pathway: evidence from clinical studies

C. Schalkwijk, C. Stehouwer, L. Engelen, 2013, Diabetes, obesity & metabolism.

Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.

M. Huijberts, G. Nijpels, J. Dekker, 2013, The Journal of clinical endocrinology and metabolism.

Reference values for local arterial stiffness. Part A: carotid artery

S. Laurent, P. Boutouyrie, P. Segers, 2015, Journal of hypertension.

The glycation pathway in type 2 diabetes and cardiovascular disease

L. Engelen, 2012 .

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

H. Parving, N. Chaturvedi, L. Tarnow, 2017, Cardiovascular Diabetology.

Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study

N. Chaturvedi, C. Stehouwer, C. Schalkwijk, 2015, Cardiovascular Diabetology.

Low 25-hydroxyvitamin D 2 and 25-hydroxyvitamin D 3 levels are independently associated with macroalbuminuria , but not with retinopathy and macrovascular disease in type 1 diabetes : the EURODIAB prospective complications study Cardiovascular Diabetology

N. Chaturvedi, C. Schalkwijk, S. Eussen, 2015 .

Reference values for local arterial stiffness. Part B: femoral artery

S. Laurent, P. Boutouyrie, P. Segers, 2015, Journal of hypertension.

The association between the −374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies

E. Feskens, G. Nijpels, J. Dekker, 2010, Journal of hypertension.

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

N. Chaturvedi, C. Stehouwer, C. Schalkwijk, 2015, Cardiovascular Diabetology.

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study

J. Geleijnse, N. Chaturvedi, C. Stehouwer, 2014, Diabetologia.